Efrat Fleissig1,2, Mehreen Adhi1, Douglas K Sigford1, Charles C Barr3. 1. Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, 301 E Muhammad Ali Blvd., Louisville, KY, 40202, USA. 2. Department of Ophthalmology, Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. 3. Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, 301 E Muhammad Ali Blvd., Louisville, KY, 40202, USA. ccbarr01@louisville.edu.
Abstract
PURPOSE: To analyze the foveal avascular zone (FAZ) in patients with diabetes and no retinopathy vs. controls using OCT angiography (OCT-A). METHODS: Prospective, observational clinical study. Type I and II diabetics with no retinopathy and healthy control patients underwent OCT-A. The FAZ size and capillary density were calculated using Image J and Adobe Photoshop CS8. Statistical analysis was performed using one-way ANOVA with Tukey's multiple comparison test and the Pearson correlation test. RESULTS: Fifty-two eyes of 28 diabetic patients and 28 eyes of 16 healthy controls were enrolled. Type I diabetes patients had a longer disease duration than type II (30.3 ± 10.3 vs. 12.3 ± 9.7 years). The mean superficial capillary plexus (SCP) of the FAZ area was 0.27 ± 0.1, 0.36 ± 0.14, and 0.27 ± 0.12 mm2, for the type I, type II, and controls (p = 0.0058) and was significantly larger in type II diabetics (p < 0.05). The mean DCP (deep capillary plexus) FAZ was significantly larger in type II diabetics vs. controls (0.67 ± 0.2 and 0.52 ± 0.16 mm2 respectively) (p < 0.05). Both type I and type II SCP capillary density were significantly lower than the controls (p < 0.05, p < 0.005), and DCP capillary density was significantly lower in type II vs. controls (p < 0.005). CONCLUSIONS: Type I patients showed fewer changes in the FAZ than the type II group, although their duration of diabetes was longer. Larger studies are needed to better analyze the differences between type I and type II diabetics.
PURPOSE: To analyze the foveal avascular zone (FAZ) in patients with diabetes and no retinopathy vs. controls using OCT angiography (OCT-A). METHODS: Prospective, observational clinical study. Type I and II diabetics with no retinopathy and healthy control patients underwent OCT-A. The FAZ size and capillary density were calculated using Image J and Adobe Photoshop CS8. Statistical analysis was performed using one-way ANOVA with Tukey's multiple comparison test and the Pearson correlation test. RESULTS: Fifty-two eyes of 28 diabeticpatients and 28 eyes of 16 healthy controls were enrolled. Type I diabetespatients had a longer disease duration than type II (30.3 ± 10.3 vs. 12.3 ± 9.7 years). The mean superficial capillary plexus (SCP) of the FAZ area was 0.27 ± 0.1, 0.36 ± 0.14, and 0.27 ± 0.12 mm2, for the type I, type II, and controls (p = 0.0058) and was significantly larger in type II diabetics (p < 0.05). The mean DCP (deep capillary plexus) FAZ was significantly larger in type II diabetics vs. controls (0.67 ± 0.2 and 0.52 ± 0.16 mm2 respectively) (p < 0.05). Both type I and type II SCP capillary density were significantly lower than the controls (p < 0.05, p < 0.005), and DCP capillary density was significantly lower in type II vs. controls (p < 0.005). CONCLUSIONS: Type I patients showed fewer changes in the FAZ than the type II group, although their duration of diabetes was longer. Larger studies are needed to better analyze the differences between type I and type II diabetics.
Entities:
Keywords:
Deep capillary plexus; Foveal avascular zone; OCT angiography; Superficial capillary plexus
Authors: Rohit Varma; Neil M Bressler; Quan V Doan; Michelle Gleeson; Mark Danese; Julie K Bower; Elizabeth Selvin; Chantal Dolan; Jennifer Fine; Shoshana Colman; Adam Turpcu Journal: JAMA Ophthalmol Date: 2014-11 Impact factor: 7.389
Authors: Talisa E de Carlo; Adam T Chin; Marco A Bonini Filho; Mehreen Adhi; Lauren Branchini; David A Salz; Caroline R Baumal; Courtney Crawford; Elias Reichel; Andre J Witkin; Jay S Duker; Nadia K Waheed Journal: Retina Date: 2015-11 Impact factor: 4.256
Authors: Neil H White; Wanjie Sun; Patricia A Cleary; William V Tamborlane; Ronald P Danis; Dean P Hainsworth; Matthew D Davis Journal: Diabetes Date: 2010-02-11 Impact factor: 9.461
Authors: Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Barbara E K Klein Journal: Ophthalmology Date: 2008-11 Impact factor: 12.079
Authors: John M Lachin; Neil H White; Dean P Hainsworth; Wanjie Sun; Patricia A Cleary; David M Nathan Journal: Diabetes Date: 2014-09-09 Impact factor: 9.461
Authors: Giovanni William Oliverio; Ida Ceravolo; Ahsan Bhatti; Costantino John Trombetta Journal: Int Ophthalmol Date: 2020-11-06 Impact factor: 2.031
Authors: Juan D Arias; Francisco J Arango; Maria Margarita Parra; Ronald M Sánchez-Ávila; Gustavo A Parra-Serrano; Andrea T Hoyos; Silvia J Granados; Eduardo J Viteri; Ivetteh Gaibor-Santos; Yanny Perez Journal: Ther Adv Ophthalmol Date: 2021-10-21